# US 2025/0027130 A1 · Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0027130 A1
- Document ID: US20250027130A1
- Status: Published application
- Kind: A1
- Application number: 18/804,140
- Filed: 2024-08-14
- Published: 2025-01-23
- Earliest claimed: 2022-02-27
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Alanna Schepartz Shrader; Riley Carson B. Fricke; Cameron V. Swenson
- Web page: https://patentgrep.com/patent/US20250027130A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 9/93: {Ligases (6)}
- C12Y 601/01026: Pyrrolysine-tRNAPyl ligase (6.1.1.26)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Methods to generate novel acyl-tRNA species deploy an orthogonal synthetase that accepts α-hydroxy acids, α-thio acids, N-formyl-L-α-amino acids, and/or α-carboxyl acid monomers (malonic acids) that are formally precursors to polyketide natural products.

## Claims

### Claim 1

A method to generate novel acyl-tRNA species, comprising reacting an orthogonal synthetase with a tRNA and a non-L-α-amino acid selected from α-hydroxy acids, α-thio acids, N-formyl-L-α-amino acids and α-carboxyl acid monomers (malonic acids) that are formally precursors to polyketide natural products, to generate the novel acyl-tRNA species.

### Claim 2 (depends on 1)

The method of claim 1, wherein the orthogonal synthetase accepts α-hydroxy acids, α-thio acids, N-formyl-L-α-amino acids, and α-carboxyl acid monomers (malonic acids) that are formally precursors to polyketide natural products.

### Claim 3 (depends on 1)

The method of claim 1, wherein the orthogonal synthetase is a pyrrolysyl-tRNA synthetase (PylRS).

### Claim 4 (depends on 1)

The method of claim 1, wherein the orthogonal synthetase is a pyrrolysyl-tRNA synthetase (PylRS), and the PylRS is a Methanomethylophilus alvus PylRS (MaPylRS) or a MaPylRS substitution variant.

### Claim 5 (depends on 1)

The method of claim 1, wherein the orthogonal synthetase is a pyrrolysyl-tRNA synthetase (PylRS), and the PylRS is a Methanomethylophilus alvus PylRS (MaPylRS) substitution variant comprising substitutions at N166 and V168.

### Claim 6 (depends on 1)

The method of claim 1, wherein the orthogonal synthetase is a pyrrolysyl-tRNA synthetase (PylRS), and the PylRS is a Methanomethylophilus alvus PylRS (MaPylRS) substitution variant comprising MaFRS1 (N166A, V168L), MaFRS2 (N166A, V168K), or MaFRSA (N166A, V168A).

### Claim 7 (depends on 1)

The method of claim 1, further comprising providing the acyl-tRNA species in a translation system, wherein the non-L-α-amino acid is incorporated into a protein.

### Claim 8 (depends on 1)

The method of claim 1, further comprising providing the acyl-tRNA species in a translation system, wherein the non-L-α-amino acid is incorporated into a sequence-defined non-protein hetero-polymer.

### Claim 9

A composition or kit comprising an isolated orthogonal synthetase that accepts α-hydroxy acids, α-thio acids, N-formyl-L-α-amino acids or α-carboxyl acid monomers (malonic acids) that are formally precursors to polyketide natural products.

### Claim 10 (depends on 9)

The composition or kit of claim 9, wherein the orthogonal synthetase accepts α-hydroxy acids, α-thio acids, N-formyl-L-α-amino acids, and α-carboxyl acid monomers (malonic acids) that are formally precursors to polyketide natural products.

### Claim 11 (depends on 10)

The composition or kit of claim 10, wherein the orthogonal synthetase is a pyrrolysyl-tRNA synthetase (PylRS).

### Claim 12 (depends on 11)

The composition or kit of claim 11, wherein the PylRS is a Methanomethylophilus alvus PylRS (MaPylRS) or a MaPylRS variant.

### Claim 13 (depends on 12)

The composition or kit of claim 12, wherein the PylRS is MaPylRS variant comprising substitutions at N166 and V168.

### Claim 14 (depends on 13)

The composition or kit of claim 13, wherein the PylRS is MaPylRS variant MaFRS1 (N166A, V168L), MaFRS2 (N166A, V168K), or MaFRSA (N166A, V168A).
